Interesting mwo3
"Analysts put relenza sales for 2009 at about US$1.1B."
Based on this article and some of my rough calculations I'm revising my estimate from $40m to $50m.
I also expect GSK to announce a massive increase in Relenza production.
What would that do to the shareprice?